YuYu Pharma signed 10 antihistamine CMO contracts this month

Kim Minyoung / approved : 2024-04-16 03:18:29
  • -
  • +
  • 인쇄

(Photo= YuYu Pharma)

 

[Alpha Biz= Reporter Kim Minyoung] YuYu Pharma announced on the 15th that it has signed a new consignment production contract with 10 pharmaceutical companies this month. The new growth engine, the CMO (medicine consignment production) business, is cruising as it has signed a series of contracts.

YuYu Pharma recently signed a contract with six companies for Fexofenadine 120mg, which was approved by the Ministry of Food and Drug Safety, including Kyungnam Pharmaceutical, Non-preservative Drug, CMG Pharmaceutical, Nexfarm Korea, Eden Pharma and Medica Korea. Fexofenadine 120mg is a differentiated item that improves patient convenience by reducing formulation size by 44% compared to existing products.

Launched last year, Fexofenadine 60mg has signed additional contracts with four other companies: CMG Pharmaceutical, Medica Korea, Edenpharma and Hutex Pharmaceutical. As a result, Fexofenadine 60mg consignment production has increased to a total of 10 companies, including existing Samjin Pharmaceutical, Ahn-Gook Pharmaceutical, Daewoo Pharmaceutical, Non-preservative Drug, Nex Pharm Korea and Dibio.

 

 

Alphabiz Kim Minyoung (kimmy@alphabiz.co.kr)

어플

주요기사

Bomb Threats Target Major Korean Companies Including Samsung Electronics2025.12.19
FSS Raises Consumer Alert to “Warning” Over Secondary Scams Linked to Coupang Data Breach2025.12.19
Final U.S. Defense Authorization Bill Omits Provisions Supporting South Korea-Japan Shipbuilding Cooperation2025.12.19
Controversy Surrounds KT’s Former Outside Director Cho Seung-ah Amid Dual Directorship Issue2025.12.19
Samsung Securities Lowers LG Energy Solution Target Price to KRW 480,000 Amid Contract Cancellations2025.12.19
뉴스댓글 >

건강이 보이는 대표 K Medical 뉴스

HEADLINE

PHOTO

많이 본 기사